Growth Metrics

Protalix BioTherapeutics (PLX) EPS (Basic) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 560.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 560.00%
Dec 31, 2025 -177.78%
Sep 30, 2025 -25.00%
Jun 30, 2025 116.74%
Mar 31, 2025 16.67%
Dec 31, 2024 190.00%
Sep 30, 2024 233.33%
Jun 30, 2024 -110.34%
Mar 31, 2024 -20.00%
Dec 31, 2023 -42.86%
Sep 30, 2023 57.14%
Jun 30, 2023 363.64%
Mar 31, 2023 0.00%
Dec 31, 2022 50.00%
Sep 30, 2022 22.22%
Jun 30, 2022 56.00%
Mar 31, 2022 64.29%
Dec 31, 2021 -566.67%
Sep 30, 2021 35.71%
Jun 30, 2021 -92.31%
Mar 31, 2021 -240.00%
Dec 31, 2020 50.00%
Sep 30, 2020 41.67%
Jun 30, 2020 75.00%
Mar 31, 2020 120.00%
Dec 31, 2019 105.00%
Sep 30, 2019 40.00%
Jun 30, 2019 13.33%
Mar 31, 2019 0.00%
Dec 31, 2018 93.13%
Sep 30, 2018 -344.44%
Mar 31, 2018 -4.17%
Dec 31, 2017 -29,000.00%
Sep 30, 2017 -28.57%
Mar 31, 2017 -433.33%
Dec 31, 2016 -102.47%
Sep 30, 2016 -75.00%
Jun 30, 2016 -83.33%
Mar 31, 2016 -50.00%
Mar 31, 2015 -175.00%
Mar 31, 2014 60.00%
Dec 31, 2013 -220.00%
Sep 30, 2013 0.00%
Jun 30, 2013 -163.64%
Mar 31, 2013 -28.57%
Dec 31, 2012 62.22%
Sep 30, 2012 160.00%
Jun 30, 2012 168.75%
Mar 31, 2012 16.67%
Dec 31, 2011 34.92%
Sep 30, 2011 -433.33%
Jun 30, 2011 -233.33%